Skip to main content
logo
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.9364
-0.0836 (-8.20%)
At close: Jun 2, 2026, 4:00 PM EDT
0.9300
-0.0064 (-0.68%)
After-hours: Jun 2, 2026, 6:23 PM EDT

Akebia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
251427427241106400
Market Cap Growth
-62.34%0.03%77.06%127.10%-73.44%-3.52%
Enterprise Value
280.26290.74417.58224.4978.82283.93
Last Close Price
0.941.611.901.240.582.26
Forward PE
-82.56----
PS Ratio
1.061.812.671.240.361.89
PB Ratio
9.9813.10-8.69-7.8920.315.41
P/TBV Ratio
9.2212.70-8.15-7.6020.175.07
P/FCF Ratio
4.096.31----
P/OCF Ratio
4.066.29----
EV/Sales Ratio
1.211.232.611.150.271.34
EV/EBITDA Ratio
23.1011.74----
EV/EBIT Ratio
25.8412.37----
EV/FCF Ratio
4.674.29----
Debt / Equity Ratio
1.331.48-0.86-0.8512.050.46
Debt / EBITDA Ratio
7.441.95----
Debt / FCF Ratio
0.810.71----
Net Debt / Equity Ratio
-4.15-4.190.20-0.020.87-0.25
Net Debt / EBITDA Ratio
-17.31-5.510.74-0.08-0.110.08
Net Debt / FCF Ratio
-1.89-2.020.24-0.03-0.060.07
Asset Turnover
0.630.790.690.650.660.36
Inventory Turnover
3.092.483.963.982.943.09
Quick Ratio
1.301.421.070.821.010.77
Current Ratio
1.401.551.411.181.431.04
Return on Equity (ROE)
-27.56%64.49%174.03%409.60%-237.83%-175.37%
Return on Assets (ROA)
1.56%11.30%-21.83%-15.48%-18.25%-45.08%
Return on Invested Capital (ROIC)
10.03%48.58%-48.87%-32.10%-39.53%-120.10%
Return on Capital Employed (ROCE)
2.63%13.30%-35.85%-25.12%-32.65%-72.94%
FCF Yield
24.47%15.84%----
Buyback Yield / Dilution
-21.26%-21.91%-12.53%-2.56%-10.14%-19.85%
Total Shareholder Return
-21.26%-21.91%-12.53%-2.56%-10.14%-19.85%
SEC Filings: 10-K · 10-Q